PPA
LEGN icon

Parametric Portfolio Associates’s Legend Biotech LEGN Stock Holding History

Parametric Portfolio Associates’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$294K Sell
8,094
-20,147
-71% -$796K ﹤0.01% 3289
2021
Q4 		$1.32M Buy
+28,241
New +$1.43M ﹤0.01% 2664

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Parametric Portfolio Associates's LEGN Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Legend Biotech (LEGN) stake by 71% in Q1 2022, selling an estimated $796K and leaving 8,094 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #3289.

Parametric Portfolio Associates first reported a position in LEGN in Q4 2021 and has held it in 2 quarters since. The position peaked at $1.32M in Q4 2021. 141 funds tracked by Wall St. Rank hold LEGN as of Q1 2022.

  • Parametric Portfolio Associates held 8,094 shares of Legend Biotech worth $294K as of Q1 2022.
  • Parametric Portfolio Associates sold 20,147 Legend Biotech shares in Q1 2022, an estimated $796K.
  • Legend Biotech made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3289 holding.
  • Parametric Portfolio Associates first reported a position in Legend Biotech in Q4 2021 and has held it in 2 quarters since.
  • Parametric Portfolio Associates's Legend Biotech position peaked at $1.32M in Q4 2021.
  • 141 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.